Bliss GVS Pharma Ltd.
Search Company
  You can view the Income statement for the last 5 years.
ISIN No INE416D01022 52Wk High (Rs.) 293 BV (Rs.) 109.38 FV (Rs.) 1.00
Bookclosure 18/02/2026 52Wk Low (Rs.) 118 EPS (Rs.) 12.21 P/E (X) 22.75
Mkt Cap. (Rs. Cr.) 2,937.23 P/BV (X) 2.54 Div Yield (%) 0.54 Mkt Lot 1
 
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue1.001.001.001.001.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)9.176.564.858.238.97
Diluted EPS (Rs.)9.176.504.778.108.81
Cash EPS (Rs.)12.099.117.089.6610.27
Book Value[Excl.RevalReserv]/Share (Rs.)109.20100.4794.4289.9682.12
Book Value[Incl.RevalReserv]/Share (Rs.)109.20100.4794.4289.9682.12
Dividend / Share (Rs.)1.500.500.500.500.50
Revenue From Operations / Share (Rs.)68.9963.3257.8357.4561.38
PBDIT / Share (Rs.)16.8012.1313.4413.5313.68
PBIT / Share (Rs.)13.879.5611.1912.0712.34
PBT / Share (Rs.)12.628.946.7111.1112.19
Net Profit / Share (Rs.)9.166.554.848.218.94
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)24.3519.1523.2323.5522.28
PBIT Margin (%)20.1015.1019.3421.0120.11
PBT Margin (%)18.2814.1111.6019.3319.86
Net Profit Margin (%)13.2710.338.3614.2814.56
Return on Networth / Equity (%)8.386.515.129.1210.88
Return on Capital Employeed (%)12.489.2011.3112.7414.42
Return On Assets (%)7.205.654.397.508.58
Long Term Debt / Equity (X)0.000.010.030.040.02
Total Debt / Equity (X)0.000.040.060.080.10
Asset Turnover Ratio (%)0.560.560.520.530.62
      
LIQUIDITY RATIOS     
      
Current Ratio (X)4.906.166.594.764.10
Quick Ratio (X)4.245.515.834.273.63
Inventory Turnover Ratio (X)7.577.793.743.584.04
Dividend Payout Ratio (NP) (%)0.007.6010.286.075.58
Dividend Payout Ratio (CP) (%)0.005.467.025.154.85
Earning Retention Ratio (%)0.0092.4089.7293.9394.42
Cash Earning Retention Ratio (%)0.0094.5492.9894.8595.15
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)15.9919.4124.2314.0132.80
Interest Coverage Ratio (Post Tax) (%)9.9111.4816.809.5021.79
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)2169.681118.521075.66734.56733.93
EV / Net Operating Revenue (X)2.971.681.781.231.15
EV / EBITDA (X)12.218.757.655.215.17
MarketCap / Net Operating Revenue (X)3.121.861.951.241.25
Retention Ratios (%)0.0092.3989.7193.9294.41
Price / BV (X)1.971.171.190.790.93
Price / Net Operating Revenue (X)3.121.861.951.241.25
EarningsYield0.040.050.040.110.11